e-ISSN: Pending

Browse the failure-mode index

96 real negative results, null findings, and replication failures in Immunology and Microbiology. Search the index →

WASTE indexes published research — it does not host or republish full papers. Each entry is a metadata record compiled from open scholarly databases; the abstract is shown in full only where the paper is openly licensed, otherwise a short excerpt under fair use. Classifications are automated and approximate.

Negative / Null Result ReportOpen accessImmunology and Microbiology

LNG-IUD and breast cancer: Number 2 – 2026

Mariane Nunes de Nadai, Carolina Sales Vieira, Cristina Falbo Guazzelli et al. · 2026 · Revista Brasileira Ginecologia e Obstetrícia

Key points• Breast cancer is the most common type of cancer among women worldwide.• There is concern regarding the use of hormonal contraceptives and their possible relationship with the risk of breast cancer.• Several studies have evaluated the association between hormonal contraceptives and breast cancer, achieving heterogeneous results.• Some observational studies and systematic reviews suggest an association between levonorgestrel intrauterine device (LNG-IUD) use and breast cancer.However, these findings are limited by confounding factors and methodological weaknesses in the studies.• Whe

View details →
Replication FailureOpen accessImmunology and Microbiology

A phase 3, randomized, double-blind, multicenter, placebo-controlled study of S-588410, a five-peptide cancer vaccine as an adjuvant therapy after curative resection in patients with esophageal squamous cell carcinoma

Tomoki Makino, Hiroshi Miyata, Takushi Yasuda et al. · 2024 · Esophagus

BACKGROUND: S-588410, a cancer peptide vaccine (CPV), comprises five HLA-A*24:02-restricted peptides from five cancer-testis antigens. In a phase 2 study, S-588410 was well-tolerated and exhibited antitumor efficacy in patients with urothelial cancer. Therefore, we aimed to evaluate the efficacy, immune response, and safety of S-588410 in patients with completely resected esophageal squamous cell carcinoma (ESCC). METHODS: This phase 3 study involved patients with HLA-A*24:02-positive and lymph node metastasis-positive ESCC who received neoadjuvant therapy followed by curative resection. After

View details →
Negative / Null Result ReportOpen accessImmunology and Microbiology

Evaluation of antimicrobial resistance governance across 193 countries to inform the 2026 Global Action Plan update

Weiye Chen, Yige Zeng, Jinxin Zheng et al. · 2026 · Nature Medicine

Antimicrobial resistance (AMR) poses a major global health threat, yet the effectiveness of national action plans (NAPs) remains uncertain. Here we developed a multidimensional One Health governance index through a structured Delphi expert…

View details →
Negative / Null Result ReportOpen accessImmunology and Microbiology

Endothelial STING and STAT1 mediate IFN-independent effects of IL-6 in an endotoxemia-induced model of shock

Nina Martino, Erin Sanders, Ramon Bossardi Ramos et al. · 2025 · Journal of Clinical Investigation

Severe systemic inflammatory reactions, including sepsis, often lead to shock, organ failure, and death, in part through an acute release of cytokines that promote vascular dysfunction. However, little is known about the vascular endothelial signaling pathways regulating the transcriptional profile in failing organs. Our work focused on signaling downstream of IL-6, due to its clinical importance as a biomarker for disease severity and predictor of mortality. Here, we show that loss of endothelial expression of the IL-6 pathway inhibitor SOCS3 promoted a type I IFN-like (IFNI-like) gene signat

View details →
Negative / Null Result ReportOpen accessImmunology and Microbiology

Tumor Subtype Determines Therapeutic Response to Chimeric Polypeptide Nanoparticle–based Chemotherapy in Pten -deleted Mouse Models of Sarcoma

Rebecca D. Dodd, Amanda Scherer, Wesley Huang et al. · 2020 · Clinical Cancer Research

Abstract Purpose: Nanoparticle-encapsulated drug formulations can improve responses to conventional chemotherapy by increasing drug retention within the tumor and by promoting a more effective antitumor immune response than free drug. New…

View details →